ArticleBMC surgery2025
Incidence and risk factors of postoperative delirium in patients undergoing elective lung cancer surgery : a retrospective study using the national inpatient sample database.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Delirium in diabetic ketoacidosis: a multicenter observational study of occurrence, associated factors and outcomes from 578,204 hospitalizations.Journal of endocrinological investigation · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundLung cancer is the world's deadliest cancer, and surgery offers cure for over 75% of patients. However, postoperative delirium (POD) impairs recovery, accelerates cognitive decline, and increases mortality. Despite evidence that multicomponent prevention can avert 30-40% of POD, its incidence and predictors in lung cancer surgery remain under-studied.
methodsWe conducted a retrospective cohort study of adults (≥ 18 years) undergoing elective lung cancer surgery resection from 2010 to 2019 using the U.S. National Inpatient Sample. Emergency admissions, rib fractures, and preexisting delirium or dementia were excluded. POD was identified by ICD-9/10 codes. We extracted demographics, comorbidities, perioperative complications, length of stay, and costs. Wilcoxon rank-sum and χ² tests compared groups, and univariable and multivariable logistic regression-with stepwise selection and Bonferroni correction-identified independent POD predictors. Analyses were performed in R, with P < 0.05.
resultsAmong 30,813 resections, 1,499 patients (4.86%) developed POD. Age ≥ 71 years (OR 2.10; 95% CI 1.75-2.51) and 61-70 years (OR 1.59; 1.35-1.88), female sex (OR 1.12; 1.01-1.24), teaching-hospital status (OR 1.38; 1.21-1.57), and more extensive resections (lobectomy OR 1.43; 1.28-1.60; pneumonectomy OR 2.58; 2.06-3.23) increased POD risk, whereas urban hospitals were protective (OR 0.71; 0.55-0.91). Preoperative neurological disorders (OR 5.62; 5.02-6.29), psychoses (OR 1.62; 1.35-1.95), fluid-electrolyte disorders (OR 1.27; 1.14-1.42), and hypertension (OR 1.21; 1.08-1.36) were independent predictors. Postoperative arrhythmia, deep-vein thrombosis, stroke, shock, urinary infection, and hypoxemia further elevated risk; chronic pulmonary disease and respiratory failure were protective.
conclusionsPOD complicates nearly 5% of lung cancer resections. Key demographic, clinical, and institutional factors identify high-risk patients who may benefit from targeted, multicomponent prevention strategies in thoracic surgery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.